UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014846
Receipt number R000017252
Scientific Title Evaluation of early pre-cutting using cannulating sphincterotome for selective bile duct cannulation
Date of disclosure of the study information 2014/08/12
Last modified on 2015/10/25 13:19:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of early pre-cutting using cannulating sphincterotome for selective bile duct cannulation

Acronym

ATOMIC trial

Scientific Title

Evaluation of early pre-cutting using cannulating sphincterotome for selective bile duct cannulation

Scientific Title:Acronym

ATOMIC trial

Region

Japan


Condition

Condition

biliary tract disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the selective biliary deep cannulation (SBDC) using cannulating sphincterotome

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II,III


Assessment

Primary outcomes

SBDC rate
Adverse event (pancreatitis, perforation, bleeding)
procedure duration time (for SBDC, for EST)

Key secondary outcomes

Unsuccessful factors for SBDC and factors for adverse event for cannulation using cannulating sphincterotome


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Cannulating sphincterotome

Interventions/Control_2

The algorithm for SBDC used before

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Naive pappila
Candidate for EST
No coaglopathy
No surgical altered upper GI tract except for B1
Obtained written IC

Key exclusion criteria

No naive papilla
Caglopathy
Surgical altered upper GI tract
Minor
No written IC

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name TESSHIN BAN

Organization

Nagoya Daini Red Cross Hospital

Division name

Dept. of Gastroentelorogy and Hepatology

Zip code


Address

2-9 Myokencho, showa-ku, Nagoya, Japan

TEL

052-832-1121

Email

venzo@nagoya2.jrc.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name TESSHIN BAN

Organization

Nagoya Daini Red Cross Hospital

Division name

Dept. of Gastroentelorogy and Hepatology

Zip code


Address

2-9 Myokencho, showa-ku, Nagoya, Japan

TEL

052-832-1121

Homepage URL


Email

venzo@nagoya2.jrc.or.jp


Sponsor or person

Institute

Nagoya Daini Red Cross Hospital

Institute

Department

Personal name



Funding Source

Organization

NO funding souece

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 08 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 07 Month 03 Day

Date of IRB


Anticipated trial start date

2014 Year 08 Month 12 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 08 Month 12 Day

Last modified on

2015 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017252


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name